The FEI Tribunal has issued a Consent Award in an equine anti-doping case involving a Banned Substance.
In this case, the horse Dactyle D’Aqui (FEI ID 106XH16/UAE), tested positive for the Banned Substance Testosterone, following samples taken at the CEI2* 120 – Bou Thib (UAE), 24-25 December 2021.
The athlete Muhammad Ali Fazal Amin (FEI ID 10103705/PAK (UAE)) and the trainer, Ahmed Ali Salman Hassan Al Sabri (FEI ID 10041041/UAE), both elected to admit the rule violation and accept the consequences in order to benefit from a six-month reduction of the otherwise applicable ineligibility period of 18 months.
In its final decision the FEI Tribunal disqualified the athlete and the horse from the event and imposed an 18-month ineligibility period on the athlete and the trainer; the provisional suspension each already served shall be credited against the imposed ineligibility period. The Horse was provisionally suspended for 2 months as of the date of the Notification Letter. The athlete and Trainer were also fined CHF 5,000 each and the trainer was asked to pay costs of CHF 1,000.
The full Decision for Muhammad Ali Fazal Amin is available here.
The full Decision for Ahmed Ali Salman Hassan Al Sabri is available here.
Separately, the FEI has announced two new adverse analytical findings (AAF) involving equine prohibited substances. Both cases involve *Banned Substances and a Controlled Medication Substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
In the first Jumping case, the athlete has been provisionally suspended until the FEI Tribunal renders its decision. The horse has been provisionally suspended for two months from the date of notification.
Horse: FULL OPTION DU BORGET (106UY09/NED)
Person Responsible: Agustin Covarrubias (10032966/CHI)
Event: CSIYH1* incl. 8yo - Opglabbeek (BEL), 15-18.06.2022
Prohibited Substance(s): O-Desmethylvenlafaxine
Date of notification: 25 July 2022
In the second Dressage case, the athlete has also been provisionally suspended until the FEI Tribunal renders its decision. The horse has been provisionally suspended for two months from the date of notification.
Horse: AZIBO DE MORAN (107UB68/ESP)
Person Responsible: Maria De Las Mercedes Gonzalez Abad (10139475/ESP)
Event: CDIYH - Segovia (ESP) 07-10.07.2022,
Prohibited Substance(s): Reserpine, Altrenogest
Date of notification: 2 August 2022
Notes to Editors:
FEI Clean Sport - human athletes
The FEI is part of the collaborative worldwide movement for doping-free sport led by the World Anti-Doping Agency (WADA). The aim of this movement is to protect fair competition as well as athlete health and welfare.
WADA’s Prohibited List identifies the substances and methods prohibited in- and out-of-competition, and in particular sports. The substances and methods on the List are classified by different categories (e.g., steroids, stimulants, gene doping).
As a WADA Code Signatory, the FEI runs a testing programme for human athletes based on WADA’s List of Prohibited List of Substances and Methods and on the Code-compliant FEI Anti-Doping Rules for Human Athletes (ADRHA).
For further information, please consult the Clean Sport section of the FEI website here.
FEI Equine Prohibited Substances
The FEI Prohibited Substances List is divided into two sections: Controlled Medication and *Banned Substances. Controlled Medication substances are medications that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) Substances should never be found in the body of the horse and are prohibited at all times.
In the case of an adverse analytical finding (AAF) for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification (with the exception of certain cases involving a Prohibited Substance which is also a **Specified Substance). The horse is provisionally suspended for two months.
Information on all substances is available on the searchable FEI Equine Prohibited Substances Database.